跳至主要内容
临床试验/EUCTR2009-012428-10-GB
EUCTR2009-012428-10-GB进行中(未招募)不适用

Preventing depression relapse / recurrence in NHS settings through mindfulness-based cognitive therapy (MBCT). - PREVENT

niversity of Exeter0 个研究点目标入组 420 人开始时间: 2009年10月1日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
420

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Inclusion: A diagnosis of recurrent major depressive disorder in full or partial remission according to the DSM-IV, with 3 or more previous major depressive episodes; aged 18 or older; and on a therapeutic dose of ADM in line with the British National Formulary (BNF) and NICE guidance. We include older adults with depression on the basis of the high prevalence of depression in older adults and a promising pilot study of MBCT with this group (Smith, 2004).
  • Exclusion: patients who are currently depressed, co-morbid diagnoses of current substance dependence; organic brain damage; current/past psychosis, including bipolar disorder; persistent antisocial behaviour; persistent self-injury requiring clinical management/therapy; and formal concurrent psychotherapy.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Currently depressed, co-morbid diagnoses of current substance dependence; organic brain damage; current/past psychosis, including bipolar disorder; persistent anti-social behaviour; persistent self-injury requiring clinical management/therapy; and formal concurrent psychotherapy.

研究者

发起方
niversity of Exeter

相似试验